The specialized platform Ciencia en Chile published an article highlighting the recent seminar “Early Diagnosis and Biomarkers: Key Insights from a Parkinson’s Discussion,” an event sponsored by CEDENNA and organized by the University of Santiago de Chile.
The publication underscores the focus of the event, which addressed one of the main current challenges in tackling neurodegenerative diseases: advancing toward earlier and more accurate diagnosis, based on the development of biomarkers and a deeper understanding of the biological mechanisms underlying Parkinson’s disease.
The seminar brought together national and international experts, who discussed topics such as the role of inflammation, the use of biomarkers like alpha-synuclein, and new diagnostic tools aimed at detecting the disease before the onset of clinical symptoms. This is particularly relevant, considering that Parkinson’s is often diagnosed at later stages, when significant neurological damage has already occurred.
In this context, the article also highlights the interdisciplinary nature of the event, which brought together basic and clinical research with the aim of advancing toward concrete solutions for patients.
From CEDENNA’s perspective, this type of initiative is part of a broader strategy aimed at strengthening the link between cutting-edge research and health applications, promoting the development of knowledge with real impact on the diagnosis and treatment of highly prevalent diseases.
👉 You can read the full article on Ciencia en Chile here:
https://www.cienciaenchile.cl/diagnostico-temprano-y-biomarcadores-claves-en-conversatorio-sobre-parkinson/
20 de abril de 2026
